Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 2995902)

Published in J Allergy (Cairo) on December 01, 2010

Authors

Mona Bafadhel1, Amisha Singapuri, Sarah Terry, Beverley Hargadon, William Monteiro, Ruth H Green, Peter H Bradding, Andrew J Wardlaw, Ian D Pavord, Christopher E Brightling

Author Affiliations

1: Institute for Lung Health, Clinical Sciences Wing, University Hospitals of Leicester, Groby Road, Leicester LE3 9QP, UK.

Articles cited by this

Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08

Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) (2008) 9.45

Development and validation of a questionnaire to measure asthma control. Eur Respir J (1999) 9.35

Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med (2000) 8.09

Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med (2008) 5.80

The global burden of asthma. Chest (2006) 5.74

Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med (2003) 5.38

Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med (2007) 3.95

The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85

Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med (2005) 3.48

Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23

Relation of body mass index to asthma and atopy in children: the National Health and Nutrition Examination Study III. Thorax (2001) 3.10

Obesity may increase the incidence of asthma in women but not in men: longitudinal observations from the Canadian National Population Health Surveys. Am J Epidemiol (2002) 3.01

The epidemiology of obesity and asthma. J Allergy Clin Immunol (2005) 2.87

Association between body mass index and allergy in teenage girls in Taiwan. Clin Exp Allergy (1999) 2.59

The mechanisms, diagnosis, and management of severe asthma in adults. Lancet (2006) 2.40

Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med (2002) 2.36

Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat (2007) 1.86

Use of body mass index of adults in assessing individual and community nutritional status. Bull World Health Organ (1995) 1.54

Obesity increases the risk of incident asthma among adults. Eur Respir J (2005) 1.33

Weight loss and asthma control in severely obese asthmatic females. Respir Med (2007) 1.14

Body mass index and asthma in the military population of the northwestern United States. Arch Intern Med (2001) 1.12

Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80 year-old Italian population. Clin Nutr (2008) 1.07

Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma. Respir Med (2008) 1.01

The incidence of asthma in young adults. Chest (2005) 0.98

Body mass index and response to emergency department treatment in adults with severe asthma exacerbations: a prospective cohort study. Chest (2007) 0.98

Influence of obesity on the prevalence and clinical features of asthma. Clin Invest Med (2008) 0.95

Advanced statistics: linear regression, part II: multiple linear regression. Acad Emerg Med (2004) 0.80

Articles by these authors

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet (2002) 8.57

Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med (2009) 8.36

Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52

Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma. Am J Respir Crit Care Med (2013) 4.95

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med (2014) 4.95

Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med (2009) 4.83

Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med (2006) 4.83

Asthma control during the year after bronchial thermoplasty. N Engl J Med (2007) 4.79

Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10

Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest (2006) 3.59

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med (2011) 3.58

Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med (2014) 3.50

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35

Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 2.74

Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol (2012) 2.68

Prevalence, pathogenesis, and causes of chronic cough. Lancet (2008) 2.60

The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med (2007) 2.44

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax (2007) 2.37

Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest (2010) 2.29

Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol (2002) 2.28

Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels. FASEB J (2013) 2.16

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.13

Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med (2011) 2.07

Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med (2003) 1.98

The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med (2005) 1.95

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol (2002) 1.92

Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J Allergy Clin Immunol (2008) 1.92

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med (2010) 1.91

Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol (2005) 1.87

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med (2006) 1.86

Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med (2012) 1.85

The influence of age on induced sputum differential cell counts in normal subjects. Chest (2004) 1.82

Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest (2010) 1.73

Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol (2007) 1.71

Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis (2006) 1.61

Detection of cough signals in continuous audio recordings using hidden Markov models. IEEE Trans Biomed Eng (2006) 1.53

Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am J Respir Crit Care Med (2006) 1.53

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol (2004) 1.52

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest (2007) 1.46

Peptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary disease. Respirology (2013) 1.45

Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol (2013) 1.45

Validation of a photoacoustic gas analyser for the measurement of functional residual capacity using multiple-breath inert gas washout. Respiration (2014) 1.44

Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J Allergy Clin Immunol (2011) 1.38

A comparison of the validity of different diagnostic tests in adults with asthma. Chest (2002) 1.36

An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines. Chest (2006) 1.33

Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J (2006) 1.30

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med (2002) 1.27

Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulm Med (2011) 1.24

Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6. J Immunol (2008) 1.23

Cough frequency, cough sensitivity and health status in patients with chronic cough. Respir Med (2005) 1.22

Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J Allergy Clin Immunol (2010) 1.21

Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax (2013) 1.20

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes. Thorax (2010) 1.19